David Elfant

Title: David Elfant: Innovator in Drug Dosage Determination

Introduction

David Elfant is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of drug administration through his innovative patent. His work focuses on improving the methods used to determine drug dosage regimens for patients.

Latest Patents

David Elfant holds a patent for "Drug dosage determination devices and methods." This patent relates to devices and methods for determining an administration regimen of a drug to a subject. The process involves computing the amount of drug to be administered per elemental period of time and evaluating combinations of at least two dosage forms against different criteria. This invention is particularly useful for drugs that are administered routinely over prolonged periods, such as in the prophylaxis of hemophilia.

Career Highlights

David Elfant is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on developing innovative solutions for drug administration. His expertise in this area has positioned him as a valuable asset in the field of pharmaceuticals.

Collaborations

David has collaborated with notable colleagues, including Geraint Iwan Davies and Martin Jenkins. These collaborations have further enhanced his research and development efforts in drug dosage determination.

Conclusion

David Elfant's contributions to drug dosage determination highlight his innovative spirit and dedication to improving patient care. His patent and work at Hoffmann-La Roche Inc. demonstrate the impact of his inventions in the pharmaceutical industry.